Dr Mike Leach has developed compounds, known as UoG-alpha and UoG-beta, that can inhibit the multiple cytokine proteins that can cause death by respiratory collapse, following Covid 19 infection. These compounds can be used within a drug therapy to prevent our immune system from disabling the body’s lung function during a cytokine storm; one of the contributing factors in Covid-19 deaths. This treatment could potentially also help protect cancer and organ transplant patients.
Further reading
-
Apprentices of the Alliance
Alliance universities are some of the foremost providers of degree apprenticeships, with apprentices studying everything from Nursing, to Quantity Surveying, to Automotive Engineering all the way to Digital Design. This…
-
Hattie’s story – University of Brighton
My Clearing success story at Brighton My account as a student who went through the Clearing process and successfully got onto the course of my dreams! My Personal Clearing Experience …
-
Coventry University says…
Six key questions students in Clearing should ask this year Coventry University Provost Ian Dunn The countdown to the biggest day of thousands of students’ lives so far has begun.…